Informational Webinar on Avapritinib Clinical Trial Program in GIST – presented by Blueprint Medicines
Tuesday, August 20, Blueprint Medicines is working with The Life Raft Group and GIST Support International to host a webinar providing a data update from the registration-enabling NAVIGATOR trial of the investigational treatment avapritinib in patients with PDGFRA Exon 18 mutant GIST and fourth-line GIST. These data were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2019. Please see here for the press release summarizing the data and the slides presented at ASCO.
The webinar will be held on August 20th beginning at 4:00 p.m., Eastern Time (1:00 p.m., Pacific Time). Maria Roche, Senior Medical Director at Blueprint Medicines, will provide an overview of the data presented at ASCO and an update on ongoing or planned studies in multiple lines of GIST treatment. We invite patients with GIST and their families to participate in this informational webinar – see details to access the webinar below.
Please submit suggested questions that you would like to be addressed during the webinar to patients@blueprintmedicines.com by Thursday, August 15th.
